Follow
Zhanna Gaulen
Zhanna Gaulen
PhD
Verified email at helse-bergen.no
Title
Cited by
Cited by
Year
Design of a randomized controlled trial of extended-release naltrexone versus daily buprenorphine-naloxone for opioid dependence in Norway (NTX-SBX)
N Kunøe, A Opheim, KK Solli, Z Gaulen, K Sharma-Haase, ZH Latif, ...
BMC Pharmacology and Toxicology 17, 1-10, 2016
372016
Health and social issues among older patients in opioid maintenance treatment in Norway
Z Gaulen, SE Alpers, SEL Carlsen, S Nesvåg
Nordic Studies on Alcohol and Drugs 34 (1), 80-90, 2017
152017
Availability of extended-release naltrexone may increase the number of opioid-dependent individuals in treatment: extension of a randomized clinical trial
KK Solli, N Kunoe, ZEH Latif, K Sharma-Haase, A Opheim, P Krajci, ...
European addiction research 25 (6), 303-309, 2019
132019
Beyond medication: life situation of older patients in opioid maintenance treatment
SEL Carlsen, Z Gaulen, SE Alpers, M Fjaereide
Addiction Research & Theory 27 (4), 305-313, 2019
82019
Interest in extended release naltrexone among opioid users
K Sharma Haase, N Kunøe, A Opheim, Z Gaulen, ALM Njå, ZE Latif, ...
European addiction research 22 (6), 301-305, 2016
82016
The predictive value of degree of preference for extended-release naltrexone for treatment adherence, opioid use, and relapse
Z Gaulen, IH Brenna, LT Fadnes, J Šaltytė Benth, KK Solli, N Kunoe, ...
European Addiction Research 28 (1), 56-67, 2022
52022
Risk of Relapse Among Opioid‐Dependent Patients Treated With Extended‐Release Naltrexone or Buprenorphine‐Naloxone: A Randomized Clinical Trial
A Opheim, Z Gaulen, KK Solli, ZH Latif, LT Fadnes, JŠ Benth, N Kunøe, ...
The American Journal on Addictions 30 (5), 453-460, 2021
42021
Life satisfaction among individuals with opioid use disorder receiving extended-release naltrexone: A 12-week randomized controlled trial and a 36-week follow-up
Z Gaulen, JŠ Benth, LT Fadnes, IH Brenna, L Tanum
Journal of Substance Abuse Treatment 135, 108656, 2022
22022
Risk of relapse to non-opioid addictive substances among opioid dependent patients treated with an opioid receptor antagonist or a partial agonist: A randomized clinical trial
A Opheim, JŠ Benth, KK Solli, PS Kloster, LT Fadnes, N Kunøe, Z Gaulen, ...
Contemporary Clinical Trials 135, 107360, 2023
12023
An Overview of Youth Substance Abuse Recovery Strategies in Norway
Z Gaulen, SEL Carlsen
Journal of Groups in Addiction & Recovery 11 (4), 228-239, 2016
12016
Pre-treatment preference, opioid use, and life satisfaction among heroin dependent users receiving treatment with buprenorphine-naloxone or extended-release naltrexone: A 12 …
Z Gaulen
The University of Bergen, 2023
2023
Front & Back Matter
M Bleckwenn, L Heister, M Weckbecker, K Weckbecker, M Mücke, ...
European Addiction Research 22 (6), 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–12